The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
Alexandra AlbusYannick KronimusMonika Burg-RoderfeldHendrik van der WurpDieter WillboldTamar ZiehmRichard DodelJean Alexander RossPublished in: Biomolecules (2023)
Our findings indicate that nAbs-α-Syn concentrations or affinities in healthy and diseased persons do not differ, independent of mutations in LRRK2.
Keyphrases